Tandem Labs
West Trenton, New Jersey - October 4, 2004 - Tandem Labs, a leading bioanalytical contract research organization (CRO), welcomes Roger Demers as a Senior Research Scientist.
"His practical experience and unique troubleshooting expertise makes him one of the best method development scientists in the industry," says Jean Pineault, General Manager and Vice President of Sales., "We are excited to have Roger Demers on board and welcome his knowledgeable contributions to the Tandem Labs' team."
Mr. Demers joins Tandem Labs with 17 years of experience in various mass spectrometry platforms including 12 years with triplequadrupoles. He was one of the first in the world to use an API-III+ in 1989 (Serial Number: 008) to commercially quantitate NCEs in biological matrices. Prior to joining Tandem Labs, he was the Senior Mass Spectrometry Scientist at Maxxam Analytics in Mississauga, Ontario, Canada. In the past several years, Mr. Demers has developed and validated numerous bioanalytical methods on LC/MS/MS.
NWT, Inc. is a Utah corporation operating a division called Tandem Labs with facilities in Salt Lake City, Utah and West Trenton, New Jersey. Since 1992, the focus has been the application of mass spectrometry expertise (LC/MS/MS) in support of new drug development for the pharmaceutical and biopharmaceutical industries. This specialization has resulted in the emergence of Tandem Labs as a leading bioanalytical clinical research organization (CRO). A diverse worldwide client portfolio includes some of the largest pharmaceutical corporations as well as small virtual companies. The Tandem Labs' structure supports large 10,000+ sample studies and small studies of fewer than 100 samples. Tandem Labs' ultimate goal is to build long lasting relationships by continually meeting and exceeding clients' expectations.
Search